Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Warby Parker Inc.NYSE: WRBY

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 57.9%

Gross margin was 57.9% in Q2 FY2026, up 5.0 pp from a year earlier. On a trailing-twelve-month basis it was 54.7%, up 0.2 pp year over year. Over 3 fiscal years it narrowed by 3.1 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
57.9%+3.9 pp QoQ
Last fiscal yearDec 2025
54.0%-1.4 pp YoY
LTMJun 2026
54.7%+0.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.0 pp——
1 year-1.4 pp——
3 years-3.1 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
54.0%
Year-over-year change
-1.4pp

Gross Margin vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's LTM Jun 2026 gross margin of 54.7% is the 5th highest of the 10 companies compared; the peer median is 48.9%.
  • Its year-over-year change of +0.2 pp is the 6th highest of 10, against a peer median of +0.6 pp.
  • Over three fiscal years its change of -3.1 pp compares with a peer median of +2.4 pp.
WRBY Competitors Peer median
Gross Margin for WRBY and competitors
Company Period LTM level YoY 3-year change
BEAMBeam Therapeutics Inc.LTM Jun 2026100.0% +0.0 pp+495.5 pp
LMATLeMaitre Vascular, Inc.LTM Mar 202672.4% +3.6 pp+6.6 pp
BHCBausch Health Companies Inc.LTM Jun 202671.8% +1.1 pp-0.3 pp
HAEHaemonetics CorporationLTM Jun 202657.4% +0.6 pp+2.4 pp
WRBYWarby Parker Inc.LTM Jun 202654.7% +0.2 pp-3.1 pp
XRAYDENTSPLY SIRONA Inc.LTM Mar 202648.9% -2.6 pp-4.2 pp
QDELQuidelOrtho CorporationLTM Mar 202645.0% -2.0 pp-12.6 pp
ICUIICU Medical, Inc.LTM Jun 202637.6% +1.7 pp+6.2 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 202629.9% +1.5 pp+4.7 pp
ITGRInteger Holdings CorporationLTM Jul 202623.7% -1.3 pp-3.0 pp
Peer median (excluding WRBY) 48.9%+0.6 pp+2.4 pp

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue540.8M598.11M669.77M771.32M871.91M
Cost of Revenue223.05M257.05M304.54M344.48M401.33M
Gross Profit317.75M341.06M365.22M426.83M470.58M
Gross Margin58.8%57.0%54.5%55.3%54.0%
Research & Development00000
Selling, General & Admin461.41M452.27M421.57M440.05M475.92M
Operating Expenses461.41M452.27M437.22M456.95M475.92M
Depreciation & Amortization21.87M31.86M38.55M45.87M50.28M
EBITDA(122.14M)(78.03M)(24.21M)26.35M53.32M
EBITDA Margin-22.6%-13.0%-3.6%3.4%6.1%
Operating Income(143.66M)(111.2M)(72M)(30.11M)(5.34M)
Operating Margin-26.6%-18.6%-10.7%-3.9%-0.6%
Interest Income01.31M9.23M10.6M8.38M
Interest Expense347K0000
Other Income / Expenses(347K)1.31M9.23M10.6M8.38M
Income Before Tax(144.01M)(109.9M)(62.76M)(19.52M)3.04M
Pre-Tax Margin-26.6%-18.4%-9.4%-2.5%0.3%
Income Tax Expense263K497K433K875K1.4M
Net Income(144.27M)(110.39M)(63.2M)(20.39M)1.64M
Net Margin-26.7%-18.5%-9.4%-2.6%0.2%
EPS (Basic)(1.39)(0.96)(0.54)(0.17)0.01
EPS (Diluted)(1.39)(0.96)(0.54)(0.17)0.01
Weighted Avg Shares113.62M114.94M117.39M120.39M122.67M
Weighted Avg Shares (Diluted)113.62M114.94M117.39M120.39M125.1M

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.